EMD-52253

Single-particle
2.0 Å
EMD-52253
3D View Gallery
Deposition: 04/12/2024
Map released: 17/12/2025
Last modified: 01/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52253
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9hlg summary report (pdf.gz) Map and 9hlg FULL report (pdf.gz)
EMICSS annotations (xml)

Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor

EMD-52253

Single-particle
2.0 Å
EMD-52253
3D View Gallery
Deposition: 04/12/2024
Map released: 17/12/2025
Last modified: 01/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus
Sample: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor
Fitted models: 9hlg

Deposition Authors: Moran E, Davies G
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents.
Vriends MBL, Moran E, Calvelo M, Hansen T, Pickles IB, Xin X, Biezeno M, Armstrong ZWB, Ferraz MJ, Li L, Lilley A, Harvey R, Filippov DV, Liao Q, Schroder SP, van der Marel GA, Artola M, Aerts JMFG, Blaza JN, Codee JDC, Rovira C, Overkleeft HS, Davies GJ
(2026) PNAS , 123 , e2504045123 - e2504045123
PUBMED: 41871250
DOI: doi:10.1073/pnas.2504045123
ISSN: 1091-6490
ASTM: PNASA6
Grant Support: